Xeris Biopharma Holdings Inc (XERS)

Total Costs & Expenses

$86.93M

Quarterly · Period ending: · USD

XERS logo

XERS Total Costs & Expenses

Latest reported$86.93M
XERS Quarterly Total Costs & Expenses ($5.00M → $86.93M)
High-resolution chart · PNG

XERS total costs & expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Xeris Biopharma Holdings Inc Total Costs & Expenses — Quarterly (USD)
Period endingTotal Costs & Expenses (USD)
86,927,000
75,211,000
69,034,000
67,649,000
67,057,000
63,209,000
58,420,000
67,161,000
56,252,000
54,883,000
54,231,000
53,233,000
53,987,000
46,473,000
48,314,000
48,505,000
44,222,000
51,147,000
69,940,000
35,393,000
34,693,000
24,935,000
26,515,000
23,192,000
24,232,000
30,042,000
34,665,000
30,405,000
34,380,000
25,685,000
21,115,000
15,525,000
13,176,000
11,993,000
9,676,000
7,742,000
5,764,000
5,003,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.